Redefining extended-spectrum β-lactamases: Balancing science and clinical need

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 1, 2009, Pages 1-4

  Giske, Christian G ^a   Sundsfjord, Arnfinn S ^b,c   Kahlmeter, Gunnar ^d   Woodford, Neil ^e   Nordmann, Patrice ^f   Paterson, David L ^g   Cantón, Rafael ^h   Walsh, Timothy R ⁱ  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d CENTRAL HOSPITAL   (Sweden)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f BICÊTRE HOSPITAL   (France)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Classification; ESBLs; KPC; Metallo lactamases; OXA

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEM; CARBAPENEM EXTENDED SPECTRUM BETA LACTAMASE; CARBAPENEMASE; CEPHALOSPORIN; CLASS A EXTENDED SPECTRUM BETA LACTAMASE; EXTENDED SPECTRUM BETA LACTAMASE; MISCELLANEOUS EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; CLASSIFICATION; EDITORIAL; ENZYME ACTIVITY; ENZYME CLASSIFICATION; HISTORY OF MEDICINE; HYDROLYSIS; NOMENCLATURE; NONHUMAN; PHENOTYPE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CLAVULANIC ACID; ENZYME INHIBITORS; GRAM-NEGATIVE BACTERIA; HUMANS; SUBSTRATE SPECIFICITY; TERMINOLOGY AS TOPIC;

EID: 57649193119     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn444     Document Type: Editorial

References (13)

1. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33.
2. Ambler RP, Meadway RJ. Chemical structure of bacterial penicillinases. Nature 1969; 222: 24-6.
3. The Sunday Times. Threat from 'new E. coli'. Times Online 23 September 2007. http://www.timesonline.co.uk/tol/news/uk/health/ article2511957.ece.
4. Livermore D. Defining an extended-spectrum β-lactamase. Clin Microbiol Infect 2008; 14 Suppl 1: 3-10.
5. Jarlier V, Nicolas MH, Fournier G et al. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-78.
6. Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33: 1131-6.
7. Poirel L, Pitout JD, Nordmann P. Carbapenemases: Molecular diversity and clinical consequences. Future Microbiol 2007; 2: 501-12.
8. Walsh TR, Toleman MA, Poirel L et al. Metallo-β-lactamases: The quiet before the storm? Clin Microbiol Rev 2005; 18: 306-25.
9. Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae - EUCAST and CLSI breakpoints. Clin Microbiol Infect 2008; 14 Suppl 1: 169-74.
10. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005; 43: 4163-7.
11. Ruppe E, Bidet P, Verdet C et al. First detection of the Ambler class C 1 AmpC β-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J Clin Microbiol 2006; 44: 4204-7.
12. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
13. Woodford N, Dallow JW, Hill RL et al. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int J Antimicrob Agents 2007; 29: 456-9.